Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Clin Breast Cancer. 2016 Mar 31;16(4):256–261. doi: 10.1016/j.clbc.2016.03.005

Table 3.

Treatment emergent adverse events occurring in ≥ 10% of patients (n =17)

Adverse Event Grade; n (%)
All grades 1-2 3 4
Fatigue 9 (53) 8 (47) 1 (6) 0
Nausea 7 (41) 7 (41) 0 0
Abdominal pain or bloating 4 (24) 4 (24) 0 0
Vaginal discharge 4 (24) 4 (24) 0 0
Dizziness 3 (18) 3 (18) 0 0
Pain, breast 3 (18) 3 (18) 0 0
Anorexia 3 (18) 3 (18) 0 0
Dyspnea 2 (12) 0 2 (12) 0
Edema 2 (12) 2 (12) 0 0
Constipation 2 (12) 2(12) 0 0
Pain, musculoskeletal 2 (12) 2 (12) 0 0
Weight gain 2 (12) 2 (12) 0 0
Vomiting 2 (12) 1 (6) 1 (6) 0
Headache 2 (12) 2 (12) 0 0
Hypoalbuminemia 7 (41) 7 (41) 0 0
Hypocalcemia 2 (12) 2 (12) 0 0